BioHarvest Sciences Inc.
BHSC
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -111.33% | -57.08% | -86.58% | -11.82% | 20.11% |
| Total Depreciation and Amortization | 37.99% | 25.09% | 9.04% | 17.98% | 24.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 751.09% | 105,225.00% | 315,066.67% | 53.80% | -362.66% |
| Change in Net Operating Assets | -167.09% | 7,275.00% | -149.71% | 345.13% | 1,915.38% |
| Cash from Operations | 9.25% | 31.57% | -0.62% | 7.78% | 10.98% |
| Capital Expenditure | -89.00% | -107.08% | -6.37% | -17.36% | -7.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -101.80% | -124.59% | -6.37% | -17.36% | -7.35% |
| Total Debt Issued | -19.04% | -21.56% | 53.35% | 76.51% | 65.23% |
| Total Debt Repaid | -40.62% | -25.14% | -20.94% | -1.39% | 5.80% |
| Issuance of Common Stock | 1,072.77% | 317.81% | -43.09% | -54.05% | -56.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 29.13% | 10.95% | 47.19% | 66.58% | 49.95% |
| Foreign Exchange rate Adjustments | 723.08% | 808.33% | 277.27% | 368.18% | 45.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 269.57% | 461.20% | 424.64% | 251.99% | 84.30% |
